Immunotherapy may not end up being as successful in treating sarcoma as it is in other types of cancer, says Katherine Thornton M.D.
Sarcoma
Latest News
Advertisement
Advertisement
The 50 cancers under the umbrella of soft tissue sarcoma are marked by genetic chaos, and a growing understanding of these mutations may lead to new treatments.
Keytruda is showing benefit to some patients with sarcoma, according to interim results from a phase 2 trial.
CURE spoke with Noah Federman about the prevalence and treatment of sarcomas in younger patients.
The FDA granted olaratumab a priority review for some people with advanced soft tissue sarcoma (STS).
Advertisement
Advertisement
Trending on CURE
1
5 Years of Prostate Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients
2
5 Years of Lung Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients
3
At 21 I Was Given 18 Months. This Year I Turned 40.
4
What Cancer Survivorship Means to Me Now, Eight Years Later
5